Cargando…
Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
BACKGROUND: Major depressive disorder (MDD) treatment is characterized by low remission rate and often involves weeks to months of treatment. Identification of pretreatment biomarkers of response may play a critical role in novel drug development, in enhanced prognostic predictions, and perhaps in p...
Autores principales: | Fan, Siyan, Nemati, Samaneh, Akiki, Teddy J., Roscoe, Jeremy, Averill, Christopher L., Fouda, Samar, Averill, Lynnette A., Abdallah, Chadi G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783890/ https://www.ncbi.nlm.nih.gov/pubmed/33458556 http://dx.doi.org/10.1177/2470547020984726 |
Ejemplares similares
-
A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants
por: Nemati, Samaneh, et al.
Publicado: (2019) -
Neurobiological studies of trauma-related psychopathology: a public health perspective
por: Akiki, Teddy J., et al.
Publicado: (2018) -
Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases
Prefrontal Global Connectivity in Depressed Patients
por: Abdallah, Chadi G., et al.
Publicado: (2018) -
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence
por: Ragnhildstveit, Anya, et al.
Publicado: (2023) -
Posttraumatic Stress Disorder and Depression Symptom Severities Are
Differentially Associated With Hippocampal Subfield Volume Loss in Combat
Veterans
por: Averill, Christopher L., et al.
Publicado: (2017)